Wird geladen...
Recently Approved and Upcoming Treatments for Narcolepsy
Narcolepsy is a chronic, disabling neurologic disorder characterised by excessive daytime sleepiness (EDS) and, in up to 60% of patients, cataplexy. Treatments for narcolepsy are aimed at improving wakefulness (e.g. modafinil, armodafinil, stimulants), reducing cataplexy attacks (e.g. sodium oxybate...
Gespeichert in:
| Veröffentlicht in: | CNS Drugs |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer International Publishing
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6982634/ https://ncbi.nlm.nih.gov/pubmed/31953791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-019-00689-1 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|